Drs Alexia Pharma Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 16-11-2024
- Paid Up Capital ₹ 7.50 M
as on 16-11-2024
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
as on 16-11-2024
- Revenue 5.31%
(FY 2023)
- Profit 5.86%
(FY 2023)
- Ebitda -1.34%
(FY 2023)
- Net Worth 12.98%
(FY 2023)
- Total Assets 13.72%
(FY 2023)
About Drs Alexia Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹2.50 M.
Chandran Narayanan, Chandrika Velayudhan, Manoj Vijayan, and Seven other members serve as directors at the Company.
- CIN/LLPIN
U52310KL2014PTC036657
- Company No.
036657
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thrissur, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Drs Alexia Pharma Private Limited offer?
Drs Alexia Pharma Private Limited offers a wide range of products and services, including Diagnostic Medical Imaging Equipment, Ultrasound Accessories, Common Disease Medicines, Cough Syrup, Sexual Wellness Products, Fertility Enhancer, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs.
Who are the key members and board of directors at Drs Alexia Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandran Narayanan  | Managing Director | 28-May-2014 | Current |
Board Members(9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandrika Velayudhan | Director | 28-May-2014 | Current |
| Manoj Vijayan | Director | 28-May-2014 | Current |
| Shiji Krishnaveni | Director | 28-May-2014 | Current |
| Umesh | Director | 28-May-2014 | Current |
| Thamarassery Mohanan | Director | 23-Jan-2017 | Current |
| Sabitha Mathramkott | Director | 23-Jan-2017 | Current |
Financial Performance of Drs Alexia Pharma.
Drs Alexia Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.31% increase. The company also saw a slight improvement in profitability, with a 5.86% increase in profit. The company's net worth Soared by an impressive increase of 12.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Drs Alexia Pharma?
In 2023, Drs Alexia Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The South Indian Bank Limited Creation Date: 04 Mar 2017 | ₹2.50 M | Open |
How Many Employees Work at Drs Alexia Pharma?
Drs Alexia Pharma has a workforce of 8 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Drs Alexia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Drs Alexia Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
